Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT

Clinical trial NCT06818305 · TERMINATED

Trial details

NCT number: NCT06818305
Sponsor: Jinling Hospital, China
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma (Kidney Cancer)Renal Cell Carcinoma (RCC)Nephrectomy Chronic Kidney Disease(CKD)

Start date: 2025-01-01
Primary completion: 2025-10-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.